Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$11.05
0.05250.48%
Last update: Dec 12, 1:57 PM
Comments
Loading...
Cadrenal Therapeutics (CVKD) Stock Price, Quote, News & History
CVKDNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cadrenal Therapeutics (CVKD) stock?
You can purchase shares of Cadrenal Therapeutics (NASDAQ:CVKD) through any online brokerage.
Who are Cadrenal Therapeutics (CVKD) competitors?
Other companies in Cadrenal Therapeutics’s space includes: Cingulate Inc (NASDAQ:CING), Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), Iterum Therapeutics PLC (NASDAQ:ITRM), Cocrystal Pharma Inc (NASDAQ:COCP) and SCYNEXIS Inc (NASDAQ:SCYX).
What is the forecast, or price target, for Cadrenal Therapeutics (CVKD) stock?
Cadrenal Therapeutics has a consensus price target of $18.00.
What is the current price for Cadrenal Therapeutics (CVKD)?
The stock price for Cadrenal Therapeutics (NASDAQ: CVKD) is $11.0525 last updated December 12, 2025 at 1:57 PM EST.
Does Cadrenal Therapeutics (CVKD) pay a dividend?
There are no upcoming dividends for Cadrenal Therapeutics.
When is Cadrenal Therapeutics (NASDAQ:CVKD) reporting earnings?
Cadrenal Therapeutics does not have any upcoming earnings scheduled.
Is Cadrenal Therapeutics (CVKD) going to split?
There is no upcoming split for Cadrenal Therapeutics.
What sector and industry does Cadrenal Therapeutics (CVKD) operate in?
Cadrenal Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
